HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Stresses Stability In Wake Of Commissioner’s Resignation

This article was originally published in The Rose Sheet

Executive Summary

FDA leadership is telling agency staff that operations will not be disrupted by the departure of Commissioner Lester Crawford after just two months in the permanent position

You may also be interested in...

FDA commissioner

Acting chief Andrew von Eschenbach, MD, is nominated by President Bush to head the agency permanently March 15. Von Eschenbach assumed the acting role last fall following the resignation of FDA Commissioner Lester Crawford (1"The Rose Sheet" Oct. 3, 2005, p. 6). Road to confirmation may be a rocky one, however: Sens. Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) threatened to place a hold on nomination until FDA issues a decision on over-the-counter switch application for Barr's Plan B emergency contraceptive...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts